so another trial.... all good 'The QB46C-H07 trial will be undertaken in the USA. This is an open label study that will enrol at least 10 patients with advanced or metastatic STS. Patients will receive up to five intratumoural treatments of tigilanol tiglate, administered four weeks apart, to evaluate the drug candidate’s efficacy and safety in the treatment of STS.'
i like the ' metastatic' word. i reckon we've already seen TT work metastatically in another trial but nil comments on the results as it was only a trial for dose rate not a trial for efficacy cheers PC
